The global Surface Plasmon Resonance Market to Witness Strong Growth Accelerated by Innovation in Sensor Technologies


 Surface plasmon resonance (SPR) refers to resonant oscillation of free electrons stimulated by light at the interface between a metal and a dielectric material. SPR biosensors are widely used for label-free detection of biomolecular interactions with high sensitivity. SPR biosensors utilize the optical properties of gold and offer advantages such as real-time detection and high-throughput detection capabilities. With growing investments in R&D to develop advanced SPR biosensors, the technology is finding wider applications in drug discovery, biosensors, basic research, and food testing. The global Surface Plasmon Resonance Market is estimated to be valued at US$ 976.1 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

Adoption of SPR has been growing at a fast pace due to continuous innovation in sensor technologies. Development of miniaturized and portable SPR sensors has enabled point-of-care testing and on-field applications. For instance, in 2020, Biosensing Instrument launched ReagentFree biosensing platform based on a portable SPR imaging instrument and microfluidic cartridges for fully integrated, reagent-less analyses. Such innovations are making SPR technologies more accessible to research institutes and diagnostic labs. Increased R&D funding and government support for development of advanced biosensors will continue to accelerate growth of the surface plasmon resonance market over the forecast period.
Segment Analysis
The global surface plasmon resonance market is dominated by the biosensor chip segment due to its extensive applications in biomedical and biochemical assays. Biosensor chips are widely used in drug discovery, toxicology, antigen-antibody and environmental monitoring, due to their ability to detect biomolecular interactions with high sensitivity.

Key Takeaways
The global surface plasmon resonance market is expected to witness high growth over the forecast period of 2023-2030. Regional analysis shows that North America currently dominates the market and is expected to maintain its leading position during the forecast period. High investments and presence of key players in the region support market growth in North America. Europe is expected to register the second-highest CAGR during the forecast period. Increasing R&D expenditure and government funding for drug discovery and development boost the market in Europe. The Asia Pacific region is projected to witness the fastest growth and emerge as the third largest market by 2030. Rapid economic development, growing biopharmaceutical industry and increasing healthcare investments are fueling demand for SPR technologies in countries such as China and India.

Key players operating in the surface plasmon resonance market are Bio-Rad Laboratories, Inc., Carterra Inc., AMETEK, Inc., Bristol Myers Squibb, Horiba, Ltd. and Bruker. Bio-Rad Laboratories, Inc. is a leading player with a wide range of high throughput and imaging SPR products. Recent acquisition of Aurora Biopharma has expanded Bio-Rad's portfolio of label-free biosensors based on surface plasmon resonance technology. Horiba's reputation in analytical and sensing instruments is driving the adoption of its SPR solution platforms in academic and industrial R&D. Bristol Myers Squibb has developed novel surface plasmon resonance imaging platforms for applications in drug discovery and antibody engineering.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more